αv integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis

I. R. Murray, Z. N. Gonzalez, J. Baily, R. Dobie, R. J. Wallace, A. C. Mackinnon, J. R. Smith, S. N. Greenhalgh, A. I. Thompson, K. P. Conroy, D. W. Griggs, P. G. Ruminski, G. A. Gray, M. Singh, M. A. Campbell, T. J. Kendall, J. Dai, Y. Li, J. P. Iredale, H. Simpson, J. Huard, B. Péault () and N. C. Henderson ()
Additional contact information
I. R. Murray: University of Edinburgh
Z. N. Gonzalez: University of Edinburgh
J. Baily: University of Edinburgh
R. Dobie: University of Edinburgh
R. J. Wallace: University of Edinburgh
A. C. Mackinnon: University of Edinburgh
J. R. Smith: University of Edinburgh
S. N. Greenhalgh: University of Edinburgh
A. I. Thompson: University of Edinburgh
K. P. Conroy: University of Edinburgh
D. W. Griggs: Edward A. Doisy Research Center
P. G. Ruminski: Edward A. Doisy Research Center
G. A. Gray: University of Edinburgh
M. Singh: Edward A. Doisy Research Center
M. A. Campbell: Edward A. Doisy Research Center
T. J. Kendall: University of Edinburgh
J. Dai: University of Texas McGovern Medical School
Y. Li: University of Texas McGovern Medical School
J. P. Iredale: University of Bristol
H. Simpson: University of Edinburgh
J. Huard: Steadman Philippon Research Institute
B. Péault: University of Edinburgh
N. C. Henderson: University of Edinburgh

Nature Communications, 2017, vol. 8, issue 1, 1-13

Abstract: Abstract Mesenchymal cells expressing platelet-derived growth factor receptor beta (PDGFRβ) are known to be important in fibrosis of organs such as the liver and kidney. Here we show that PDGFRβ+ cells contribute to skeletal muscle and cardiac fibrosis via a mechanism that depends on αv integrins. Mice in which αv integrin is depleted in PDGFRβ+ cells are protected from cardiotoxin and laceration-induced skeletal muscle fibrosis and angiotensin II-induced cardiac fibrosis. In addition, a small-molecule inhibitor of αv integrins attenuates fibrosis, even when pre-established, in both skeletal and cardiac muscle, and improves skeletal muscle function. αv integrin blockade also reduces TGFβ activation in primary human skeletal muscle and cardiac PDGFRβ+ cells, suggesting that αv integrin inhibitors may be effective for the treatment and prevention of a broad range of muscle fibroses.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-017-01097-z Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01097-z

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-017-01097-z

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().